Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03645824
Title Myelofibrosis Treated With Pacritinib Before aSCT. (HOVON134MF) (HOVON134MF)
Acronym HOVON134MF
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Stichting Hemato-Oncologie voor Volwassenen Nederland
Indications
Therapies
Age Groups: adult | senior
Covered Countries NLD | BEL

Facility Status City State Zip Country Details
BE-Antwerpen-ZNASTUIVENBERG Antwerpen Belgium Details
BE-Gent-UZGENT Gent Belgium Details
BE-Leuven-UZLEUVEN Leuven Belgium Details
BE-Roeselare-AZDELTA Roeselare Belgium Details
NL-Amsterdam-AMC Amsterdam Netherlands Details
NL-Amsterdam-VUMC Amsterdam Netherlands Details
NL-Groningen-UMCG Groningen Netherlands Details
NL-Maastricht-MUMC Maastricht Netherlands Details
NL-Nijmegen-RADBOUDUMC Nijmegen Netherlands Details
NL-Rotterdam-EMCDANIEL Rotterdam Netherlands Details
NL-Rotterdam-ERASMUSMC Rotterdam Netherlands Details
NL-Utrecht-UMCUTRECHT Utrecht Netherlands Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field